nancy beesley speares

Pharma marketing & Advertising leader, strategist, coach. Lover of all things fitness, food and family.

[nancy beesley speares @hcb_nancybeez]

@BestBuy @BestBuySupport @BestBuyCSR @KatyPolice @ArvestBank
In February, my daughter went to a Best Buy store in Springfield, Missouri and purchased a $50 item. Several hours later at a Best Buy store in Katy Texas someone walked in and purchased a $1200 iPad using her stolen debit card number. When we discovered it was fraud, we contacted the bank Who immediately issued her credit. Best Buy did their initial investigation and is claiming that it was not fraud which makes no sense since she couldn’t be in two places at one time. I have called the Best Buy support team over 11 times, filed multiple reports, including two police reports andhave left voicemails for the store manager and Katy, Texas and Arvest bank has been working to try to correct the situation. My daughter is 24 years old - $1200 is a lot of money for her. Best Buy is clearly doing some kind of inside job with their employees and no one is taking responsibility. It is truly disgraceful that customers can be treated this way. The lack of concern from the Best Buy team has been disturbing. Shame on you, Best Buy!

[steve usdin @steveusdin1]

FDA taking another look at eye therapy rejected under Makary
Advisory committee to consider low-dose atropine from Sydnexis following FDA setback.
For eight months, Sydnexis has argued that FDA's rejection of SYD-101, its low-dose atropine drop for pediatric myopia, contradicted widely accepted medical practice. The company has garnered support from ophthalmologists, the editorial page of The Wall Street Journal, and politicians. Now it will make that case to an advisory committee.

The advisory committee will not be asked to determine if Sydenxis Inc. hit the primary endpoint in its Phase III trial. In a trial the company says is the largest ever conducted in pediatric myopia, SYD-101 achieved the primary endpoint, reducing  the proportion of patients with confirmed progression of -0.75 D compared to placebo (p=0.0226), and a secondary endpoint, annual progression rate.
The committee will instead take up a more fundamental question: whether the slowing of refractive progression the trial recorded is clinically meaningful at all, and whether it would lower the future risk of the retinal complications that make high myopia dangerous. FDA says the data failed to make the case.
https://t.co/gtzwADbxTs

The answer may depend on who is sitting at the table.

[nancy beesley speares @hcb_nancybeez]

https://t.co/VxEDbba7sJ

[Wall Street Journal Opinion @WSJopinion]

We hope the FDA will stop torpedoing promising drugs, but the story of biotech firm Sydnexis’s battle with the bureaucracy suggests more obstacles ahead.
https://t.co/sLI9TDKvIk

[nancy beesley speares @hcb_nancybeez]

"I'm with you" Powerful words. Thank you to the amazing and brave officers of the @Austin_Police the city of Austin is forever indebted to you. My daughter was in one of those bars and thankfully she's ok. The amount of lives saved by your actions is immeasurable. I will never forget how you ran towards danger. You are all heroes. ♥️

[nancy beesley speares @hcb_nancybeez]

@adamfeuerstein @markland_55 @BrianSkorney 100 % agree. Ad Comms give the FDA the opportunity to LEARN and ask questions so they are not making decisions in a vacuum.

[Brian Skorney @BrianSkorney]

This is really a good take. The key issue here is that there is subjectivity around "substantial evidence", "reasonably likely", "clinically meaningful". We need to better define the regulatory criteria that we want as a society through legislation. In the mean time, we should be doing more AdComs for these things where all stakeholders can be heard and a decision can be made by a panel of experts. Empowering one person at FDA is problematic for a number of reasons.

[nancy beesley speares @hcb_nancybeez]

https://t.co/h0QlLjEGrK

Sad but true. We are truly falling behind. Approving a Low Dose Atropine is not complicated, and US kids are the ones suffering... @US_FDA @MartyMakary

[The Tailgate Tent🏈⛺️ @TheTailgateTent]

So let me get this straight...

Lane Kiffin takes LSU job, stating that recruiting to LSU, the stadium, etc. as a better chance to win a Natty than Ole Miss.

Brings entire Offensive coaching staff, including stud OC Weis Jr who thinks they can land Chambliss if he gets waiver

Fires "King of Louisiana" Frank Wilson, LSU's best recruiter. Hires his RB Coach Kevin Smith because he thinks he'll bring Lacy

Ole Miss hires Frank Wilson

Lane tries to lure away Lacy, Chambliss, Carneiro, Echols and others

Ole Miss now has commitments from Lacy and Chambliss to stay - not a single Ole Miss starter has hit the portal and only one non-starter transfering to LSU

Ole Miss and Portal Pete have signed or projected to sign:

So Miss star LB Chris Jones (133 tackles LY)
Colo DL Jeheim Oatis
FL DT Michai Boireau (#4 DL in portal)
FL DB Sharif Denson
Baylor LB Keaton Thomas
DE Jonathan Maldonado
Aub stud CB Jay Crawford

Rumored to have Deuce Knight on the way
Rumored to have a top IOL Carius Curne coming from LSU

Ole Miss currently ranks 3rd in portal ranks, LSU ranks 56th per On 3

Oh...and Ole Miss is 1 game from a Natty

[nancy beesley speares @hcb_nancybeez]

@PeteHegseth Amen indeed 🇺🇸

[nancy beesley speares @hcb_nancybeez]

@CEOElection What an amazing concept. Let’s go!!

[nancy beesley speares @hcb_nancybeez]

@DrBenTapper1 Let’s go!!!

[Andrew Pannu @andrewpannu]

Top 10 drugs to watch heading into 2023 (for drugs first approved in 2022)

Ranked by sell-side 2027 sales estimates, which may reflect more than 1 indication (i.e. Mounjaro reflects obesity + T2D)

$LLY leads the way with Mounjaro, with $BMY second ($5.8B) based on 3 approvals

[VTAMA® (tapinarof) cream, 1% @VTAMAcream]

Looking for an innovative prescription treatment option for adult plaque psoriasis? VTAMA cream is a steroid-free topical that is safe for long-term use, as demonstrated in clinical studies over 52 weeks. For full Prescribing Information click here: https://t.co/OR0Up58KRx

[Jordan Dominic @Burgundy_Soul29]

I hate whatever this new @instagram update is, please return it back to normal, I like to doom scroll while listening to my own music don’t pause my shit to play some random reel or video! I’ll decide what want to hear thanks. Stay in your lane

[nancy beesley speares @hcb_nancybeez]

@mosseri Horrible! I can’t even see my own personal feed anymore there’s so much content being thrown at me. Shame on you Instagram. You should not do something to the app that people cannot unselect or change. Bad customer service….

[nancy beesley speares @hcb_nancybeez]

@mosseri Please change it back. It’s not more immersive it’s become more annoying.

[Ads of the World by Clios @adsoftheworld]

Monster Melanoma - New Melanoma Foundation campaign by HCB Health @hcbhealth https://t.co/jKr5FHjh2u #creativity #inspiration #advertising

[Dermavant Sciences, an Organon company @dermavant]

We’re thrilled to announce the appointment of Nancy Beesley to our BOD. With nearly three decades of industry experience, Nancy will be instrumental in finalizing our commercialization efforts of a potential first-in-class therapy for adults with #PlaquePsoriasis. Welcome, NancyWe’re thrilled to announce the appointment of Nancy Beesley to our BOD. With nearly three decades of industry experience, Nancy will be instrumental in finalizing our commercialization efforts of a potential first-in-class therapy for adults with #PlaquePsoriasis. Welcome, Nancy!

[HCB Health @hcbhealth]

Today is National Taco Day and we'd be remiss if we didn't post anything from our headquarters in Austin, Texas. Tacos aren't just a food here, they are a way of life, a taste of home and all the goodness wrapped up in corn or flour. And thank you, El Arroyo for the laughs.